Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years
Authors:
- J KisickiJKJ Kisicki
- K FiskeKFK Fiske
- A LyneALA Lyne
- 1 September 2007
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (9) , 1967-1979